Literature DB >> 26807364

Impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine indexes of cardiac sympathetic innervation.

Teresa Pellegrino1, Valentina Piscopo1, Antonio Boemio1, Barbara Russo1, Gianluca De Matteis1, Sara Pellegrino1, Sara Maria Delle Acque Giorgio1, Manuela Amato1, Mario Petretta1, Alberto Cuocolo1.   

Abstract

BACKGROUND: This study was designed to assess the impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine (MIBG) indexes of cardiac sympathetic innervation.
METHODS: Forty-five patients with heart failure (HF) (38 men, age 58±15 years) underwent (123)I-MIBG cardiac imaging. Of these patients, 10 were obese [body mass index (BMI) ≥30 kg/m(2)]. Ten-minute planar images of the thorax in anterior view were performed 15 minutes ("early" image) and 3 hours and 50 minutes ("late" image) after tracer administration in both supine- and prone-position. Early and late (123)I-MIBG heart-to-mediastinum (H/M) ratios and washout rate were computed.
RESULTS: In overall study population, early and late (123)I-MIBG H/M ratios and washout rate were comparable between supine- and prone-position acquisitions. Obese patients had a lower early and late (123)I-MIBG H/M ratios both in supine (P<0.01) and prone (P<0.05) positions compared to non-obese subjects.
CONCLUSIONS: Our results indicate that in HF patients, obesity has a significant impact on (123)I-MIBG indexes of cardiac sympathetic innervation. Prone-position did not change early and late (123)I-MIBG H/M ratios and washout rate compared to supine position both in obese and non-obese HF patients.

Entities:  

Keywords:  Metaiodobenzylguanidine cardiac imaging (MIBG cardiac imaging); heart-to-mediastinum ratios (H/M ratios); obesity; prone-position acquisition; washout rate

Year:  2015        PMID: 26807364      PMCID: PMC4700238          DOI: 10.3978/j.issn.2223-4292.2015.11.03

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  17 in total

1.  Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT.

Authors:  Keiichiro Yoshinaga; Yuuki Tomiyama; Osamu Manabe; Katsuhiko Kasai; Chietsugu Katoh; Kenichi Magota; Eriko Suzuki; Ken-Ichi Nishijima; Yuji Kuge; Yoichi M Ito; Nagara Tamaki
Journal:  Ann Nucl Med       Date:  2014-06-21       Impact factor: 2.668

2.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Authors:  Arnold F Jacobson; Roxy Senior; Manuel D Cerqueira; Nathan D Wong; Gregory S Thomas; Victor A Lopez; Denis Agostini; Fred Weiland; Harish Chandna; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2010-02-25       Impact factor: 24.094

3.  Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.

Authors:  Teresa Pellegrino; Mario Petretta; Serena De Luca; Stefania Paolillo; Antonio Boemio; Raffaella Carotenuto; Maria Piera Petretta; Carmine di Nuzzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

Review 4.  Cardiac sympathetic imaging with mIBG in heart failure.

Authors:  Ignasi Carrió; Martin R Cowie; Junichi Yamazaki; James Udelson; Paolo G Camici
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

5.  Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction.

Authors:  Tetsuo Sasano; M Roselle Abraham; Kuan-Cheng Chang; Hiroshi Ashikaga; Kevin J Mills; Daniel P Holt; John Hilton; Stephan G Nekolla; Jun Dong; Albert C Lardo; Henry Halperin; Robert F Dannals; Eduardo Marbán; Frank M Bengel
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

6.  Assessment of cardiac autonomic control by heart period variability in patients with early-onset familial obesity.

Authors:  M Petretta; D Bonaduce; E de Filippo; G F Mureddu; L Scalfi; F Marciano; V Bianchi; L Salemme; G de Simone; F Contaldo
Journal:  Eur J Clin Invest       Date:  1995-11       Impact factor: 4.686

7.  123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.

Authors:  Jeroen J Bax; Otakar Kraft; Alfred E Buxton; Jan Gunnar Fjeld; Petr Parízek; Denis Agostini; Juhani Knuuti; Albert Flotats; James Arrighi; Africa Muxi; Marie-Jeanne Alibelli; Gopa Banerjee; Arnold F Jacobson
Journal:  Circ Cardiovasc Imaging       Date:  2008-07-30       Impact factor: 7.792

Review 8.  Cardiac autonomic imaging with SPECT tracers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

9.  Comparison of overall obesity and body fat distribution in predicting risk of mortality.

Authors:  Jared P Reis; Caroline A Macera; Maria R Araneta; Suzanne P Lindsay; Simon J Marshall; Deborah L Wingard
Journal:  Obesity (Silver Spring)       Date:  2009-02-05       Impact factor: 5.002

10.  Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.

Authors:  Hein J Verberne; G Aernout Somsen; Pavol Povinec; Berthe L F van Eck-Smit; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

View more
  10 in total

1.  Challenges and opportunities of noninvasive cardiac imaging in obesity.

Authors:  Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2016-09-20       Impact factor: 5.952

Review 2.  123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation.

Authors:  Paola Gargiulo; Wanda Acampa; Gaetano Asile; Vincenza Abbate; Ermanno Nardi; Federica Marzano; Roberta Assante; Carmela Nappi; Antonio Luca Maria Parlati; Christian Basile; Santo Dellegrottaglie; Stefania Paolillo; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-08       Impact factor: 10.057

Review 3.  Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome.

Authors:  Alberto Preda; Luca Liberale; Fabrizio Montecucco
Journal:  Heart Fail Rev       Date:  2021-11-18       Impact factor: 4.654

Review 4.  Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.

Authors:  Arnold C T Ng; Victoria Delgado; Barry A Borlaug; Jeroen J Bax
Journal:  Nat Rev Cardiol       Date:  2020-11-13       Impact factor: 32.419

5.  Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction.

Authors:  Akihiro Sunaga; Shungo Hikoso; Takahisa Yamada; Yoshio Yasumura; Masaaki Uematsu; Haruhiko Abe; Yusuke Nakagawa; Yoshiharu Higuchi; Hisakazu Fuji; Toshiaki Mano; Hiroyuki Kurakami; Tomomi Yamada; Tetsuhisa Kitamura; Taiki Sato; Bolrathanak Oeun; Hirota Kida; Takayuki Kojima; Yohei Sotomi; Tomoharu Dohi; Katsuki Okada; Shinichiro Suna; Hiroya Mizuno; Daisaku Nakatani; Yasushi Sakata
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-14       Impact factor: 9.236

6.  CMR stress testing in a patient with morbid obesity (BMI 58 kg/m2) and suspected coronary artery disease.

Authors:  Lukas Stoiber; Bernhard Schnackenburg; Rolf Gebker; Hanane Hireche-Chikaoui; Burkert Pieske; Sebastian Kelle
Journal:  BMC Cardiovasc Disord       Date:  2018-03-05       Impact factor: 2.298

Review 7.  Cardiovascular Imaging in Obesity.

Authors:  Sophie I Mavrogeni; Flora Bacopoulou; George Markousis-Mavrogenis; George Chrousos; Evangelia Charmandari
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

8.  Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age.

Authors:  G Roberts; J J Lloyd; J P M Kane; R Durcan; S Lawley; K Howe; G S Petrides; J T O'Brien; A J Thomas
Journal:  J Nucl Cardiol       Date:  2019-09-16       Impact factor: 5.952

Review 9.  Myocardial perfusion scintigraphy dosimetry: optimal use of SPECT and SPECT/CT technologies in stress-first imaging protocol.

Authors:  M Lecchi; S Malaspina; C Scabbio; V Gaudieri; A Del Sole
Journal:  Clin Transl Imaging       Date:  2016-10-31

Review 10.  Dosing Therapeutic Radiopharmaceuticals in Obese Patients.

Authors:  Merel van Nuland; Tessa F Ververs; Marnix G E H Lam
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.